AQR Capital Management’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $128K | Buy |
61,749
+34,440
| +126% | +$71.3K | ﹤0.01% | 3138 |
|
|
2025
Q1 | $60.1K | Sell |
27,309
-187,648
| -87% | -$413K | ﹤0.01% | 3072 |
|
|
2024
Q4 | $329K | Sell |
214,957
-685,150
| -76% | -$1.05M | ﹤0.01% | 2458 |
|
|
2024
Q3 | $1.79M | Buy |
900,107
+292,972
| +48% | +$583K | ﹤0.01% | 1559 |
|
|
2024
Q2 | $2.12M | Buy |
607,135
+568,238
| +1,461% | +$1.99M | ﹤0.01% | 1427 |
|
|
2024
Q1 | $108K | Buy |
38,897
+2,042
| +6% | +$5.66K | ﹤0.01% | 2331 |
|
|
2023
Q4 | $62.7K | Sell |
36,855
-85,912
| -70% | -$146K | ﹤0.01% | 2301 |
|
|
2023
Q3 | $126K | Sell |
122,767
-25,184
| -17% | -$25.9K | ﹤0.01% | 2199 |
|
|
2023
Q2 | $172K | Buy |
147,951
+6,874
| +5% | +$7.97K | ﹤0.01% | 2100 |
|
|
2023
Q1 | $213K | Buy |
141,077
+89,717
| +175% | +$135K | ﹤0.01% | 2036 |
|
|
2022
Q4 | $128K | Sell |
51,360
-1,908
| -4% | -$4.77K | ﹤0.01% | 2122 |
|
|
2022
Q3 | $225K | Buy |
+53,268
| New | +$225K | ﹤0.01% | 2018 |
|
|
2019
Q2 | – | Sell |
-13,202
| Closed | -$323K | – | 2120 |
|
|
2019
Q1 | $323K | Buy |
+13,202
| New | +$323K | ﹤0.01% | 1944 |
|
|
2014
Q3 | – | Sell |
-75,000
| Closed | -$924K | – | 2548 |
|
|
2014
Q2 | $924K | Buy |
+75,000
| New | +$924K | ﹤0.01% | 1688 |
|